U.S. Aerospace & Defense Stock News

Travere Therapeutics (TVTX) drew fresh attention after the USPTO issued a Notice of Allowance for a FILSPARI patent in IgA nephropathy, which is expected to extend certain U.S. protections into October 2037. See our latest analysis for Travere Therapeutics. The patent news lands after a strong run in the stock, with a 30-day share price return of 16.8% and a 90-day share price return of 60.32%. The 1-year total shareholder return sits at 210.53%, which suggests momentum has been building into...

Recent share weakness and earnings expectations Progressive (PGR) has drawn attention after its stock declined 1.2% in the latest session while the S&P 500 gained 0.58%, as investors look ahead to upcoming earnings expected at $3.76 per share. See our latest analysis for Progressive. Beyond the latest 1-day share price decline, Progressive’s stock has eased over longer horizons, with the share price down 8.3% year to date and the 1-year total shareholder return lower, even as the 3 and 5-year...

BioNTech (NasdaqGS:BNTX) has expanded its Supervisory Board following major late stage oncology data announcements at ASCO 2026. Prof. Iris Löw-Friedrich and Dr. Susanne Schaffert have been elected, adding experience in clinical development, oncology, and international commercialization. The board changes are described as aligning with BioNTech’s push to advance multiple pivotal cancer trials and prepare for potential future product launches. BioNTech, known for its mRNA technology...

In recent weeks, The Tour Guy launched a PayPal-enabled “Reserve Now, Pay Later” feature for select tours, while PayPal users in the U.S. gained the ability to pay Chinese merchants via WeChat Pay’s QR-code network through Tencent’s TenPay Global platform. Together, these moves highlight PayPal’s push to power flexible travel bookings and cross-border spending, extending its payment infrastructure into high-traffic international tourism corridors. We’ll now examine how PayPal’s expanded...

In May 2026, ImmunityBio announced that the FDA accepted for review its supplemental Biologics License Application to expand ANKTIVA plus BCG to BCG-unresponsive non-muscle invasive bladder cancer with papillary disease, supported by QUILT-3.032 data showing chemo-free, bladder-sparing outcomes. An interesting element of this filing is the FDA’s emphasis on whether ANKTIVA’s existing CIS data can be extrapolated to papillary-only disease, putting the drug’s mechanistic rationale and trial...

In May 2026, Alkami Technology announced that multiple regional banks, including Citizens Bank and FVSBank, adopted its MANTL onboarding and account opening solutions to modernize and automate deposit account opening across digital and branch channels. By enabling these banks to automate more than 85% of application decisions and sharply cut account opening times, MANTL highlights Alkami’s role in reshaping how smaller institutions deliver faster, compliance-focused digital banking...

Earlier this month, Healthcare Realty Holdings, L.P. entered into a US$400.0 million senior unsecured delayed draw term loan facility maturing in May 2029, with flexible SOFR- or base rate-linked pricing, an accordion option of up to US$100.0 million, and no mandatory amortization. The ability to draw this capital over a year, prepay without penalty, and operate under customary covenants highlights lender confidence in Healthcare Realty Trust’s credit profile and balance sheet...

Cipher Digital recently advanced its shift from bitcoin mining to operating industrial-scale data centers, securing roughly US$11.40 billion in contracted revenue from long-term hyperscale leases, including 300 MW of capacity for Amazon Web Services in Texas. This pivot positions Cipher Digital as a power- and infrastructure-centric partner for AI and high-performance computing workloads, drawing institutional interest toward its extensive energy footprint and hyperscale leasing...

Marvell Technology (MRVL) opened its Q1 2027 scorecard with revenue of US$2.4 billion and basic EPS of US$0.04, alongside net income of US$34.5 million, giving investors a clean read on how the new fiscal year is starting. Over the past six quarters, revenue has moved from US$1.8 billion in Q4 2025 to US$1.9 billion in Q1 2026 and then to US$2.4 billion in Q1 2027. Basic EPS has ranged from US$0.23 to US$2.22 before landing at US$0.04 this quarter, a pattern that puts the focus squarely on...

Why Illumina’s new MRD kit matters for the stock Illumina (ILMN) has drawn fresh attention after launching a whole genome based molecular residual disease research kit that targets both solid tumors and blood cancers, anchored on its NovaSeq X sequencing platform. The solution, currently in early access and backed by initial data from partners such as Mayo Clinic, broadens Illumina’s oncology research offering at a time when the company has been working to address flat sales and weaker...

In recent days, Axon Enterprise reported record Q1 results, raised its 2026 revenue growth outlook to 30%–32%, and highlighted strong demand for TASER 10, Axon Body 4, AI tools, and counter-drone solutions, supported by a new Echodyne partnership to enhance public safety drone programs. Management’s emphasis on fast-growing AI and counter-drone businesses, alongside expanding public safety use cases globally, points to a deeper, more ecosystem-driven revenue mix for Axon. With Axon now...

Omega Healthcare Investors (OHI) is preparing for a major leadership shift, with long-serving CEO C. Taylor Pickett and CFO Bob Stephenson set to retire and internally promoted successors already lined up. See our latest analysis for Omega Healthcare Investors. OHI's share price has softened recently, with the stock down 2.5% over the past week and 2.6% over the past 90 days. However, its 1-year total shareholder return of 36.3% and 3-year total shareholder return of 98.3% highlight how...

Occidental Petroleum has agreed to sell its chemicals division to Berkshire Hathaway (NYSE:BRK.A). The deal marks one of Berkshire Hathaway's largest portfolio moves since Greg Abel took over as CEO. The acquisition expands Berkshire Hathaway's footprint in the chemicals sector and uses part of its large cash reserves. Occidental Petroleum aims to simplify its business and reduce debt through this transaction. Berkshire Hathaway, known for its diversified mix of insurance, utilities,...

Recent performance snapshot Cboe Global Markets (CBOE) has caught investor attention after a period of mixed short term moves, with the stock down about 1% on the day and roughly 3.7% over the past week. See our latest analysis for Cboe Global Markets. Zooming out, Cboe Global Markets combines a 1-month share price return of 12.64% and year-to-date share price return of 38.74% with a 1-year total shareholder return of 51.82%. This points to strong momentum rather than a short-term bounce. If...

AtaiBeckley, listed as NasdaqGM:ATAI, has launched a Patient Impact Grant Program focused on supporting mental health nonprofits. The program is designed to fund community projects, education initiatives, and research that target improved mental health outcomes. Grants will be reviewed externally and involve collaboration with established mental health organizations. For investors tracking NasdaqGM:ATAI, this move adds a new dimension to how the company engages with the mental health sector...

Red Cat Holdings (RCAT) drew fresh attention after its Blue Ops maritime division moved into full rate production of the Variant 7 uncrewed surface vessel, alongside reports of potential U.S. support for domestic drone technology companies. See our latest analysis for Red Cat Holdings. The latest contract wins and Variant 7 production news arrive during a sharp upswing in sentiment, with a 1-day share price return of 32.61% and a 7-day share price return of 56.70%, while the 1-year total...

Dividend affirmation puts income focus on SM Energy (SM) SM Energy (SM) has drawn fresh attention after its board affirmed a quarterly cash dividend of $0.22 per share, with payment scheduled for June 22, 2026, to holders of record on June 8. See our latest analysis for SM Energy. The dividend decision lands after a powerful run in the stock, with SM Energy’s share price delivering a 34.72% 3 month share price return, a 62.89% year to date share price return, and a 35.71% 1 year total...

In May 2026, Raytheon, an RTX business, secured new U.S. government work ranging from next-generation naval radar software to advanced composable rocket motors, while also beginning deliveries of the Lightweight Command Launch Unit for the Javelin system to the U.S. Army. Together, these programs highlight RTX’s push toward modular, software-driven and adaptable weapon and sensor architectures that can be upgraded and tailored through software rather than repeated hardware redesigns. We’ll...

If you are wondering whether Marathon Petroleum at US$251.33 is still offering value or starting to look stretched, the headline numbers only tell part of the story. The stock has posted returns of 1.2% over the past 7 days, 8.1% over 30 days, 52.2% year to date and 60.2% over the last year, which naturally raises questions about how much of this is already reflected in the current price. Recent attention on large integrated refiners and fuels infrastructure companies has kept Marathon...

Devon Energy (NYSE:DVN) has launched exchange offers for Coterra Energy's outstanding senior notes following the completion of their merger. The company is also soliciting consents to amend certain restrictive covenants on the Coterra notes. This move is aimed at aligning Coterra's existing debt with Devon's broader capital structure after the transaction. For investors tracking Devon Energy at a share price of $44.11, the focus has recently been on the merger and related corporate actions...

If you are wondering whether Cintas stock still justifies its price tag, the key question is how its current market value compares with what the underlying business might reasonably be worth. The share price recently closed at US$173.06, with returns that rose 0.4% over the last 7 days but declined 0.7% over 30 days, 6.4% year to date, and 22.3% over 1 year. The 3 year and 5 year returns sit at 49.3% and 106.7% respectively. Recent coverage has focused on Cintas as a long term compounder in...

LiveRamp Holdings (RAMP) has drawn fresh attention after a recent swing in performance, with the stock up about 26% over the past month and roughly 38% in the past 3 months. See our latest analysis for LiveRamp Holdings. That recent surge sits alongside a 37.1% year to date share price return and a 15.2% total shareholder return over 1 year. This suggests momentum has been building after a slower longer term record that includes a 23.4% total shareholder return decline over 5 years. If...

Magnachip Semiconductor recently announced that it showcased its Medium-Voltage MOSFET portfolio for AI server, data center, and industrial power systems at PCIM Europe 2026 in Nuremberg, Germany, highlighting solutions based on Shielded-Gate Trench technology across applications such as PSUs, HPC, solar inverters, and broader automotive and industrial power platforms. This focus on high-efficiency, high-density power architectures for AI infrastructure underscores how Magnachip is leaning...

Earlier this month, Xometry, Inc. announced that Lukas Biewald, co-founder and former CEO of Weights & Biases and current SVP of AI Initiatives at CoreWeave, joined its Board of Directors and was appointed to the Nominating and Corporate Governance Committee, effective May 20, 2026. By adding a board member whose career focuses on AI infrastructure and developer platforms, Xometry is signaling a deeper commitment to AI-driven product and operational innovation. We’ll now examine how bringing...